SHSE:600062's Days Inventory is ranked better than 67.46% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs SHSE:600062: 125.60
Inventory Turnover measures how fast the company turns over its inventory within a year.
China Resources Double-Crane Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Resources Double-Crane Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.55.
China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
China Resources Double-Crane Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China Resources Double-Crane Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
China Resources Double-Crane Pharmaceutical Co Days Inventory Related Terms
China Resources Double-Crane Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Double-Crane Pharmaceutical Co Days Inventory Chart
China Resources Double-Crane Pharmaceutical Co Annual Data
SHSE:600062 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Double-Crane Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Double-Crane Pharmaceutical Co (SHSE:600062) has a Days Inventory of 122.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Resources Double-Crane Pharmaceutical Co and its competitors. This is near median its historical median of 125.18. Over the past decade, China Resources Double-Crane Pharmaceutical Co's Days Inventory has ranged from 111.31 to 151.76. According to the industry distribution chart, China Resources Double-Crane Pharmaceutical Co ranks #299 out of 919 companies in the Drug Manufacturers industry, placing it in the top 32.5%.
Is China Resources Double-Crane Pharmaceutical Co's Days Inventory too high?
China Resources Double-Crane Pharmaceutical Co's current Days Inventory of 122.00 is near median its 10-year median of 125.18. Over the past 10 years, this metric has ranged from a low of 111.31 to a high of 151.76. The Drug Manufacturers industry median Days Inventory is 164.38. China Resources Double-Crane Pharmaceutical Co's value of 122.00 is 25.8% below this industry median. Based on the distribution chart, China Resources Double-Crane Pharmaceutical Co ranks #299 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Resources Double-Crane Pharmaceutical Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Resources Double-Crane Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Resources Double-Crane Pharmaceutical Co ranks #299 out of 919 companies for Days Inventory. This puts China Resources Double-Crane Pharmaceutical Co in the upper half of its industry. The industry median Days Inventory is 164.38. China Resources Double-Crane Pharmaceutical Co's value of 122.00 is 25.8% below this benchmark. Historically, China Resources Double-Crane Pharmaceutical Co's own Days Inventory has ranged from 111.31 to 151.76 over the past decade. While the company's 10-year median is 125.18 vs. the industry median of 164.38, China Resources Double-Crane Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Double-Crane Pharmaceutical Co's current Days Inventory of 122.00 is 25.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China Resources Double-Crane Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Double-Crane Pharmaceutical Co's current Days Inventory is 122.00, which is near median its own 10-year median of 125.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Double-Crane Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Double-Crane Pharmaceutical Co (SHSE:600062) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.77, compared to a current price of ¥16.57 — trading 11.7% below its estimated fair value. The current Days Inventory is 122.00, which is near median its 10-year median of 125.18 and 25.8% below the Drug Manufacturers industry median of 164.38. China Resources Double-Crane Pharmaceutical Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For China Resources Double-Crane Pharmaceutical Co (SHSE:600062), the current Days Inventory is 122.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Double-Crane Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥16.57 is trading 11.7% below its estimated GF Value™ of ¥18.77.
GuruFocus considers China Resources Double-Crane Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:600062:
Days Inventory: 122.00 (near median its 10-year median of 125.18)
GF Value™: ¥18.77 vs. price of ¥16.57 (11.7% below fair value)
Industry Position: 25.8% below the Drug Manufacturers median (#299 of 919)
No single metric tells the full story. See the SHSE:600062 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Double-Crane Pharmaceutical Co Business Description
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
92GF Score
Get the complete analysis for SHSE:600062
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600062 has been successfully added to your 
